Figure 1. Ento-PB alleviated clinical symptoms in oxazolone-induced colitis. (a) Disease activity index; (b) representative colon pictures; (c) colon length; (d) colon weight/length ratio; (e) colon mucosal damage index. Quantitative data are shown as the mean ± standard deviation, n = 10.

SASP: sulfasalazine; *p < 0.05; **p < 0.01 vs. blank group; #p < 0.05; ##p < 0.01 vs. model group. Source: Elaborated by the authors.